Ketotifen Fumarate is the fumarate salt of ketotifen, a cycloheptathiophene analog with anti-allergic action. Ketotifen inhibits histamine (H1) receptors selectively and avoids usual effects caused by the release of histamine.
Ketotifen Fumarate: Introduction
- Ketotifen Fumarate is the fumarate salt of ketotifen, a cycloheptathiophene analog with anti-allergic action. Ketotifen inhibits histamine (H1) receptors selectively and avoids usual effects caused by the release of histamine. This agent also interferes with the release of mast cell inflammatory mediators implicated in hypersensitivity reactions, thus reducing eosinophils' chemotaxis and activation.
- Ketotifen fumarate is also an anti-asthmatic non-bronchodilator agent that prevents the effects of certain endogenous compounds that are believed to mediate inflammation, which exerts anti-allergic action.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=81672
Key Drivers and Restraints of Global Ketotifen Fumarate Market
- Rise increased prevalence of allergic asthma and allergic rhino-conjunctivitis
- According to a survey released by the World Health Organization (WHO), prevalence of existing asthma increased from 8.4% in 1999 to 9.8% in 2006 and 10.8% in 2018. Allergic asthma has risen from 5.2% in 1999 to 6.3% in 2006 and 7.5% in 2018; however, the incidence of non-allergic asthma remained constant at about 3.4% to 3.8%. Physician-diagnosed asthma, asthma medication use, and allergic rhino-conjunctivitis also increased significantly.
- Significant increase in the prevalence of allergic asthma and allergic rhino-conjunctivitis is projected to boost the demand for treatment of these diseases and subsequently, propel the ketotifen fumarate market
Request for Analysis of COVID-19 Impact on Ketotifen Fumarate Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=81672
Side-effects associated with the treatment
- Common side-effects associated with Ketotifen fumarate are burning, stinging, irritation of the eye, headache, bad taste in mouth, and increased sensitivity to light. Excess Ketotifen fumarate may lead to unwanted systemic bioavailability of active ingredients, leading to further complications.
- Children are more prone to systemic side-effects as compared to adults, which is likely to hamper the market
Pre book Ketotifen Fumarate Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=81672<ype=S
Ketotifen Fumarate Market: Segmentation
- In terms of type, the global ketotifen fumarate market can be divided into bare 0.25mg, 0.35mg, and others
- In terms of application, the global ketotifen fumarate market can be split into asthma, rhinitis, skin allergies, and others
- Based on distribution channel, the global ketotifen fumarate market can be segregated into hospital pharmacies, retail pharmacies, and online pharmacies
Asia Pacific Ketotifen Fumarate Market to Expand at a Rapid Pace
- In terms of region, the global ketotifen fumarate market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America is anticipated to be a highly attractive region of the ketotifen fumarate market during the forecast period, owing to the high cost of prescription drugs and a significant number of people in this region covered by medical insurance
- Europe and Asia Pacific are also likely to be lucrative regions of the market. This is attributed to a rise in awareness in developing countries, such as India, regarding minor eye disorders
- High incidences of ocular allergies in countries in Europe as well as prevalence of rare forms of ocular allergy is boosting the ketotifen fumarate market in the region
Read More Information: https://www.transparencymarketresearch.com/ketotifen-fumarate-market.html
Leading Players Operating in Global Ketotifen Fumarate Market
The global ketotifen fumarate market was highly fragmented in 2019. Key players operating in the global ketotifen fumarate market are:
- Akorn inc
- Allergan Inc.
- Apotex Inc.
- Bausch & Lomb Inc.
- Ciba Vision Canada Inc.
- Novartis AG
- Spectrum Pharmaceuticals
Browse More Trending Reports by Transparency Market Research:
Angiotensin II Receptor Blockers (ARBs) Market:
The global angiotensin II receptor blockers (ARBs) market can be segmented on the basis of region, application, and distribution channel. Based on the application, ARBs are used majorly in the treatment of hypertension, cardiovascular risks, and others. In terms of distribution channel, the market caters to hospital pharmacies, online pharmacies, and retail pharmacies. Based on region, the global angiotensin II receptor blockers (ARBs) market has been studied across North America, Europe, Asia Pacific, the Middle East, and Latin America. North America dominates the global angiotensin II receptor blockers (ARBs) market due to availability of accurate treatment options, advanced health care infrastructure, and early diagnosis process. Increasing obesity rate in North America is also one of the reasons for the dominance of the region on the global market, followed by Europe and Asia Pacific.
Platinum-based drugs contain coordinated complexes of platinum. These are widely used in the treatment of cancer as chemotherapeutic agents. Platinum acts as cell damaging agent for certain cancer treatments. Approximately 10% to 20% patients treated with chemotherapy receive platinum-based drugs. These drugs are used either alone or in combination with other drug treatment. Rise in prevalence of cancer is a major driver of the global platinum-based drugs market. According to the National Cancer Institute, the number of new cancer cases per year is expected to rise to 23.6 million by 2030. However, side effects associated with the drugs and development of resistance for the drug are the major restraints of the global platinum-based drugs market. Recent trends in platinum-based drugs include development of platinum drugs analog such as platinum complexes with carrier molecule in order to increase targeted concentration of drug in cancer tumor.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453